
Gout Therapeutics Global Market Report 2025
Description
Gout Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on gout therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for gout therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gout therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Corticosteroid; Diuretics
2) By Treatment: Xanthine Oxidase Inhibitor; Uricosuria Medication
3) By Disease Condition: Acute; Chronic
4) By End-Users: Hospitals; Specialty Clinics; Other End Users
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Traditional NSAIDs; Selective COX-2 Inhibitors
2) By Corticosteroid: Oral Corticosteroids; Injectable Corticosteroids
3) By Diuretics: Thiazide Diuretics; Loop Diuretics
Companies Mentioned: Sanofi-Aventis; AstraZeneca plc; LG Chem Ltd.; GlaxoSmithKline Plc; Takeda Pharmaceuticals Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on gout therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for gout therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gout therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Corticosteroid; Diuretics
2) By Treatment: Xanthine Oxidase Inhibitor; Uricosuria Medication
3) By Disease Condition: Acute; Chronic
4) By End-Users: Hospitals; Specialty Clinics; Other End Users
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Traditional NSAIDs; Selective COX-2 Inhibitors
2) By Corticosteroid: Oral Corticosteroids; Injectable Corticosteroids
3) By Diuretics: Thiazide Diuretics; Loop Diuretics
Companies Mentioned: Sanofi-Aventis; AstraZeneca plc; LG Chem Ltd.; GlaxoSmithKline Plc; Takeda Pharmaceuticals Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
200 Pages
- 1. Executive Summary
- 2. Gout Therapeutics Market Characteristics
- 3. Gout Therapeutics Market Trends And Strategies
- 4. Gout Therapeutics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
- 5. Global Gout Therapeutics Growth Analysis And Strategic Analysis Framework
- 5.1. Global Gout Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Gout Therapeutics Market Growth Rate Analysis
- 5.4. Global Gout Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Gout Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Gout Therapeutics Total Addressable Market (TAM)
- 6. Gout Therapeutics Market Segmentation
- 6.1. Global Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- Corticosteroid
- Diuretics
- 6.2. Global Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Xanthine Oxidase Inhibitor
- Uricosuria Medication
- 6.3. Global Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Acute
- Chronic
- 6.4. Global Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Specialty Clinics
- Other End-Users
- 6.5. Global Gout Therapeutics Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Traditional NSAIDs
- Selective COX-2 Inhibitors
- 6.6. Global Gout Therapeutics Market, Sub-Segmentation Of Corticosteroid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral Corticosteroids
- Injectable Corticosteroids
- 6.7. Global Gout Therapeutics Market, Sub-Segmentation Of Diuretics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Thiazide Diuretics
- Loop Diuretics
- 7. Gout Therapeutics Market Regional And Country Analysis
- 7.1. Global Gout Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Gout Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Gout Therapeutics Market
- 8.1. Asia-Pacific Gout Therapeutics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Gout Therapeutics Market
- 9.1. China Gout Therapeutics Market Overview
- 9.2. China Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Gout Therapeutics Market
- 10.1. India Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Gout Therapeutics Market
- 11.1. Japan Gout Therapeutics Market Overview
- 11.2. Japan Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Gout Therapeutics Market
- 12.1. Australia Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Gout Therapeutics Market
- 13.1. Indonesia Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Gout Therapeutics Market
- 14.1. South Korea Gout Therapeutics Market Overview
- 14.2. South Korea Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Gout Therapeutics Market
- 15.1. Western Europe Gout Therapeutics Market Overview
- 15.2. Western Europe Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Gout Therapeutics Market
- 16.1. UK Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Gout Therapeutics Market
- 17.1. Germany Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Gout Therapeutics Market
- 18.1. France Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Gout Therapeutics Market
- 19.1. Italy Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Gout Therapeutics Market
- 20.1. Spain Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Gout Therapeutics Market
- 21.1. Eastern Europe Gout Therapeutics Market Overview
- 21.2. Eastern Europe Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Gout Therapeutics Market
- 22.1. Russia Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Gout Therapeutics Market
- 23.1. North America Gout Therapeutics Market Overview
- 23.2. North America Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Gout Therapeutics Market
- 24.1. USA Gout Therapeutics Market Overview
- 24.2. USA Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Gout Therapeutics Market
- 25.1. Canada Gout Therapeutics Market Overview
- 25.2. Canada Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Gout Therapeutics Market
- 26.1. South America Gout Therapeutics Market Overview
- 26.2. South America Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Gout Therapeutics Market
- 27.1. Brazil Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Gout Therapeutics Market
- 28.1. Middle East Gout Therapeutics Market Overview
- 28.2. Middle East Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Gout Therapeutics Market
- 29.1. Africa Gout Therapeutics Market Overview
- 29.2. Africa Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Gout Therapeutics Market Competitive Landscape And Company Profiles
- 30.1. Gout Therapeutics Market Competitive Landscape
- 30.2. Gout Therapeutics Market Company Profiles
- 30.2.1. Sanofi-Aventis Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. LG Chem Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Takeda Pharmaceuticals Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 31. Gout Therapeutics Market Other Major And Innovative Companies
- 31.1. Boehringer Ingelheim International GmbH
- 31.2. Regeneron Pharmaceuticals Inc.
- 31.3. Astellas Pharma Inc.
- 31.4. Sandoz
- 31.5. Eisai Co. Ltd.
- 31.6. Horizon Pharma Plc
- 31.7. Jiangsu HengRui Medicine Co. Ltd.
- 31.8. Hikma Pharmaceuticals plc
- 31.9. Swedish Orphan Biovitrum AB
- 31.10. JW Pharmaceutical Corp
- 31.11. Lannett Company Inc
- 31.12. BioCryst Pharmaceuticals Inc.
- 31.13. Selecta Biosciences Inc.
- 31.14. Rigel Pharmaceuticals Inc.
- 31.15. CymaBay Therapeutics Inc.
- 32. Global Gout Therapeutics Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Gout Therapeutics Market
- 34. Recent Developments In The Gout Therapeutics Market
- 35. Gout Therapeutics Market High Potential Countries, Segments and Strategies
- 35.1 Gout Therapeutics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Gout Therapeutics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Gout Therapeutics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.